The role of training in effective simulated self-injection of subcutaneous depot medroxyprogesterone acetate: observations from a usability study

Usability Study ◽

Depot-medroxyprogesterone acetate use is associated with decreased risk of ovarian cancer: the mounting evidence of a protective role of progestins

Cancer Epidemiology Biomarkers & Prevention ◽

10.1158/1055-9965.epi-20-1355 ◽

2021 ◽

pp. cebp.EPI-20-1355-E.2020

Author(s):

Minh Tung Phung ◽

Alice W. Lee ◽

Anna H. Wu ◽

Andrew Berchuck ◽

Kathleen R. Cho ◽

...

Keyword(s):

Ovarian Cancer ◽

Protective Role ◽

The Role of Subcutaneous Depot Medroxyprogesterone Acetate in Equitable Contraceptive Care

Obstetrics and Gynecology ◽

10.1097/aog.0000000000004524 ◽

2021 ◽

Vol Publish Ahead of Print ◽

Author(s):

Audrey M. Burlando ◽

Anne N. Flynn ◽

Sarah Gutman ◽

Arden McAllister ◽

Andrea H. Roe ◽

...

Keyword(s):

Role of transvaginal Doppler sonography in cases of irregular uterine bleeding with depot medroxyprogesterone acetate

Menoufia Medical Journal ◽

10.4103/mmj.mmj_237_18 ◽

2019 ◽

Vol 32 (4) ◽

pp. 1355

Author(s):

MohammedWahid Al-Sarag ◽

Medhat Essam ◽

Alaa Alhalabi ◽

Haitham Hamza

Keyword(s):

Doppler Sonography ◽

Uterine Bleeding ◽

Author response for "Bone Mineral Density in Antiretroviral Therapy‐Naïve HIV‐1‐Infected Young Adults using Depot Medroxyprogesterone Acetate or Non‐Hormonal Contraceptives in Uganda"

10.1002/jbm4.10446/v2/response1 ◽

2020 ◽

Author(s):

Flavia Kiweewa Matovu ◽

Martin Nabwana ◽

Noah Kiwanuka ◽

Delia Scholes ◽

Esther Isingel ◽

...

Keyword(s):

Bone Mineral Density ◽

Young Adults ◽

Bone Mineral ◽

Author Response ◽

Mineral Density ◽

Depot Medroxyprogesterone Acetate ◽

Hiv 1

Depot Medroxyprogesterone Acetate in Teens: A Risk for Bone Health?

PEDIATRICS ◽

10.1542/peds.106.5.1137 ◽

2000 ◽

Vol 106 (5) ◽

pp. 1137-1138 ◽

Cited By ~ 6

Author(s):

Laura K. Bachrach ◽

Tim Cundy ◽

Susan M. Ott

Keyword(s):

Bone Health ◽

Faculty Opinions recommendation of Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.30424.496155 ◽

2006 ◽

Author(s):

David Hubacher

Keyword(s):

Bone Mineral Density ◽

Bone Mineral ◽

Mineral Density ◽

Faculty Opinions recommendation of Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.30424.486922 ◽

2006 ◽

Author(s):

Kate Curtis

Keyword(s):

Bone Mineral Density ◽

Bone Mineral ◽

Mineral Density ◽

Faculty Opinions recommendation of Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727748411.793536806 ◽

2017 ◽

Author(s):

Phillip Hay

Keyword(s):

Oral Contraceptives ◽

Vaginal Microbiome ◽

Combined Oral Contraceptives ◽

A semi‐mechanistic pharmacokinetic model for depot medroxyprogesterone acetate and drug‐drug interactions with antiretroviral and antituberculosis treatment.

Clinical Pharmacology & Therapeutics ◽

10.1002/cpt.2324 ◽

2021 ◽

Author(s):

Jose Francis ◽

Rosie Mngqibisa ◽

Helen McIlleron ◽

Michelle A Kendall ◽

Xingye Wu ◽

...

Keyword(s):

Drug Interactions ◽

Pharmacokinetic Model ◽

Depot Medroxyprogesterone Acetate ◽

Antituberculosis Treatment

Serum medroxyprogesterone acetate levels in new and repeat users of depot medroxyprogesterone acetate at the end of dosing interval. Smit J, Botha J, McFadyen L, et al. Contraception 2004; 69: 3–7

Journal of Family Planning and Reproductive Health Care ◽

10.1783/1471189041261537 ◽

2004 ◽

Vol 30 (3) ◽

pp. 198-198

Author(s):

Judy Murty

Keyword(s):

Dosing Interval ◽